Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The therapy of rejection.

A I Lazarovits1

  • 1Division of Nephrology, Ottawa General Hospital, Ontario.

Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|October 1, 1989
PubMed
Summary

Organ transplant rejection is a major challenge. This review covers rejection mechanisms and common immunosuppressive drugs, aiming for targeted therapy to protect the immune system.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Living Related Kidney Donors: Historical and practice perspectives.

Canadian family physician Medecin de famille canadien·2011
Same author

Prevention of diabetes mellitus in the non-obese diabetic mouse strain with monoclonal antibodies against the CD45RB molecule.

Autoimmunity·2000
Same author

Allograft tolerance induced by cyclophosphamide without prior inoculation of donor cells--immune suppression and redirection.

Transplant immunology·2000
Same author

Opposing effects of rapamycin and cyclosporin A on activation-induced Ca(2+) release.

European journal of pharmacology·1999
Same author

Cyclosporine inhibits long-term survival in cardiac allografts treated with monoclonal antibody against CD45RB.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·1999
Same author

CD45 modulation of CXCR1 and CXCR2 in human polymorphonuclear leukocytes.

European journal of immunology·1999

Area of Science:

  • Immunology
  • Transplantation Medicine
  • Pharmacology

Background:

  • Allograft rejection is a primary obstacle in organ transplantation success.
  • Understanding T cell physiology is crucial for refining rejection therapies.

Purpose of the Study:

  • To review the pathogenesis of allograft rejection.
  • To present the pharmacologic effects of common immunosuppressive agents.

Main Methods:

  • Review of existing literature on T cell physiology and transplant rejection.
  • Analysis of the mechanisms of action for azathioprine, corticosteroids, cyclosporine, and antibody therapies.

Main Results:

  • Identified key pathogenetic mechanisms underlying allograft rejection.
  • Summarized the simplified pharmacologic effects of widely used immunosuppressants.

Conclusions:

  • Current therapies aim to manage rejection by targeting T cell responses.
  • Future goals include developing therapies that specifically suppress donor-specific immune responses while preserving overall immunity.

Related Experiment Videos